eDruginfo.com
Wolters Kluwer | Lippencott Williams & Wilkins
Drug Updates | New Indications

   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

   News Capsules

   Drug Warnings

   Herbal Spotlight

   Quik Tools

   Drug Info Links

   Drug Info Bookstore

   Feedback

   Registration

   Disclaimer



cytarabine liposome injection
DepoCyt Pharmaceutical company:
Enzon Pharmaceuticals
www.enzon.com

NEW INDICATION & DOSAGE
Lymphomatous meningitis--
Adults: For induction, give 50 mg intrathecally every 14 days for two doses (weeks 1 and 3); then, for consolidation therapy, give 50 mg intrathecally every 14 days for three doses (weeks 5, 7, and 9) followed by one additional dose at week 13. Maintenance dose, 50 mg intrathecally every 28 days for four doses (weeks 17, 21, 25, and 29).
ADJUST-A-DOSE:
For patients with neurotoxicity, reduce dose to 25 mg; if neurotoxicity persists, stop therapy.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2008 by Lippincott Williams & Wilkins